Adding Docetaxel to Androgen-Deprivation Therapy in Newly Diagnosed Metastatic Prostate Cancer

被引：0
|
作者：
Vogelzang, Nicholas J. [1 ,2 ]
机构：
[1] Comprehens Canc Ctr, US Oncol Res, Las Vegas, NV 89169 USA
[2] Univ Nevada, Sch Med, Med, Las Vegas, NV 89154 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY | 2014年 / 10卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
  • [1] Adjuvant Androgen-Deprivation Therapy for Prostate Cancer Should Docetaxel Be Added?
    Vogelzang, Nicholas J.
    [J]. JAMA ONCOLOGY, 2019, 5 (05) : 633 - 634
  • [2] Timing of androgen-deprivation therapy in prostate cancer
    Del Priore, Giuseppe
    Hoffman, Steven
    [J]. LANCET ONCOLOGY, 2017, 18 (11): : E633 - E633
  • [3] Insomnia and androgen-deprivation therapy for prostate cancer
    Savard, J.
    Ivers, H.
    Simard, S.
    [J]. PSYCHO-ONCOLOGY, 2007, 16 (09) : S150 - S151
  • [4] Docetaxel or abiraterone in combination with androgen deprivation therapy for metastatic prostate cancer
    Hammerer, P.
    Manka, L.
    [J]. UROLOGE, 2019, 58 (10): : 1185 - 1197
  • [5] Is there still a role for bilateral orchidectomy in androgen-deprivation therapy for metastatic prostate cancer?
    Atta, Mohamed Adel
    Elabbady, Ahmed
    Sameh, Wael
    Sharafeldeen, Mohamed
    Elsaqa, Mohamed
    [J]. ARAB JOURNAL OF UROLOGY, 2020, 18 (01) : 9 - 13
  • [6] Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer
    Rusthoven, Chad G.
    Jones, Bernard L.
    Flaig, Thomas W.
    Crawford, E. David
    Koshy, Matthew
    Sher, David J.
    Mahmood, Usama
    Chen, Ronald C.
    Chapin, Brian F.
    Kavanagh, Brian D.
    Pugh, Thomas J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (24) : 2835 - +
  • [7] Erectile dysfunction in patients with metastatic prostate cancer treated with androgen-deprivation therapy
    Chua, Alfredo V.
    Hernandez, Aylmer Rex B.
    Strebel, Heinrik Martin Jude S.
    Jacinto, Cesar lii K.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S526 - S526
  • [8] Biopsychosocial impact of prostate cancer and androgen-deprivation therapy
    Tripp, Dean A.
    Verreault, Phylicia
    Tong, Steven
    Izard, Jason
    Black, Angela
    Siemens, D. Robert
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2017, 11 (10): : 338 - 343
  • [9] Complications of androgen-deprivation therapy in men with prostate cancer
    Chen A.C.
    Petrylak D.P.
    [J]. Current Urology Reports, 2005, 6 (3) : 210 - 216
  • [10] Androgen-deprivation therapy in the management of neuroendocrine prostate cancer
    Martinez-Cornelio, Andres
    Gonzalez-Perez, Juventino
    de Jesus Tabares-Garcia, Felipe
    Ramos-Salgado, Francisco
    Alvarado-Cabrero, Isabel
    Hernandez-Toriz, Narciso
    [J]. CIRUGIA Y CIRUJANOS, 2009, 77 (04): : 273 - 278
12345